Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3 and Thymoquinone Supplementation in COVID-19
NCT04553705Phase 3Completed
- Sponsor
- Beni Suef University
- Start
- Sep 2020
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of omega-3 fatty acid, thymoquinone in coronavirus disease 2019 (COVID-19), sponsored by Beni Suef University. Started Sep 2020; status: completed.
02
Drugs
omega-3 fatty acidthymoquinone
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04553705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04553705.